Goby Meds review: pricing, fine print, and how it ranks

The price, in words

Goby Meds offers tirzepatide but publishes no price we could capture; we track it as unpriced rather than guessing.

What the fine print says

Tracked in our universe; no price we could verify at capture.

Pharmacy & transparency

Price evidence: No price published, last verified 2026-08-05. The dispensing pharmacy is not named publicly — the single most common transparency gap in this market. Ask which pharmacy fills the prescription, whether it is 503A or 503B, and whether a certificate of analysis is available; our pharmacy guide explains what each answer means.

Nearest alternatives at this price point

If this program's terms don't fit, the same money buys NexLife at $215 (flat at every dose, no membership, named pharmacy); Yucca Health at $258 (flat at every dose, no membership, prepaid to $225); IVIM Health at $278 (source-verified) — each linked matchup runs the full head-to-head arithmetic on this exact question.

State availability

Goby Meds publishes availability of: not published. State-by-state context, exceptions, and city coverage live in the 51-state cost guides.

Five questions before checkout

Whatever the marketing says, get answers to: (1) the current all-in monthly price, in writing, since no verifiable figure is published; (2) whether the price changes at any rung of the dose ladder, and the exact tier schedule; (3) which pharmacy, by name, fills the prescription — and whether it's 503A or 503B, licensed for your state, with a certificate of analysis available; (4) the cancellation mechanics — deadline relative to renewal, written-confirmation availability, and whether any membership cancels separately. A program that answers all five plainly has already told you most of what this review can.

Visit Goby Meds — verify current pricing →Opens the provider’s own pricing page; our figures were captured 2026-08-05.

Bottom line

Until Goby Meds publishes verifiable pricing, treat any quoted figure as unconfirmed and get it in writing. For context, the verified market floor is $215/mo compounded tirzepatide and $133/mo compounded semaglutide, with brand Zepbound at $449/mo and Wegovy at $349/mo at maintenance.